Amneal Pharmaceuticals Inc (AMRX)
7.95
-0.11
(-1.36%)
USD |
NASDAQ |
Jan 10, 11:46
Amneal Pharmaceuticals SG&A Expense (Quarterly): 118.69M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Edwards Lifesciences Corp | 421.40M |
| KORU Medical Systems Inc | 5.128M |
| Eyenovia Inc | 3.729M |
| NovaBay Pharmaceuticals Inc | 2.65M |
| Palatin Technologies Inc | 2.021M |